Long intergenic non-protein coding RNA 1621 (LINC01621)

Long intergenic non-protein coding RNA 1621 (LINC01621) is a human long non-coding RNA gene, formally approved by the HUGO Gene Nomenclature Committee (HGNC:14109), transcribed but not translated into protein[5][7]. As a member of the lincRNA class, it is located in genomic regions not overlapping protein-coding genes and is predicted to function in chromatin remodeling, transcriptional control, and post-transcriptional regulation. Unlike protein-coding genes, lincRNAs such as LINC01621 operate predominantly as RNA effectors, participating in fine-tuning gene expression, often with high tissue specificity[3][9]. Despite rapid advances in characterizing lincRNA biology, the individual regulatory roles and disease associations of LINC01621 remain poorly described in current literature and major gene databases[1][5][7].

Other names

LINC01621C6orf7 (chromosome 6 open reading frame 7)

Not applicable, as there are no drugs catalogued to act via LINC01621.